bisbenzimidazole has been researched along with Burkitt Lymphoma in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Burkitt Lymphoma: A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frey, T | 1 |
Houck, DW | 1 |
Shenker, BJ | 1 |
Hoffman, RA | 1 |
1 other study available for bisbenzimidazole and Burkitt Lymphoma
Article | Year |
---|---|
Bivariate flow karyotyping with air-cooled lasers.
Topics: Air; Bisbenzimidazole; Burkitt Lymphoma; Cadmium; Chromomycin A3; Chromosomes, Human; DNA; DNA, Neop | 1994 |